{ "version": "https://jsonfeed.org/version/1.1", "title": "The Dagan Edit", "home_page_url": "https://myfacesurgeon.com/trends", "feed_url": "https://myfacesurgeon.com/feed.json", "description": "Source-linked updates about facial aesthetics, surgery, injectables, skin and recovery, connected to relevant Dagan MD educational resources.", "language": "en-US", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "items": [ { "id": "https://myfacesurgeon.com/trends/trenibote-glabellar-lines-phase3-2026", "url": "https://myfacesurgeon.com/trends/trenibote-glabellar-lines-phase3-2026", "title": "A phase 3 study puts faster-onset botulinum toxin E back into the glabellar-line conversation.", "summary": "A placebo-controlled phase 3 study published July 24, 2026 found trenibotulinumtoxinE improved moderate-to-severe glabellar lines quickly, with effects observed at hour 8, peaking at day 7 and largely returning by day 21. The study is about rapid onset and short duration in a controlled setting, not proof that a shorter-acting toxin is the right fit for every forehead or frown-line plan.", "content_text": "A placebo-controlled phase 3 study published July 24, 2026 found trenibotulinumtoxinE improved moderate-to-severe glabellar lines quickly, with effects observed at hour 8, peaking at day 7 and largely returning by day 21. The study is about rapid onset and short duration in a controlled setting, not proof that a shorter-acting toxin is the right fit for every forehead or frown-line plan.\n\nSource lens: Phase 3 placebo-controlled trial - Rapid onset and short duration still need individualized treatment planning\n\nBOTOX Cosmetic: Compare faster-onset neuromodulator data with the longer-established treatment options already in common use.\n\nInjectables Reframed: See how wrinkle treatment fits into a broader anatomy-led injectables plan rather than a one-area decision.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-28T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "trenibotulinumtoxinE", "glabellar lines", "neuromodulator", "phase 3", "botulinum toxin E", "Aesthetic Surgery Journal" ], "image": "https://myfacesurgeon.com/images/renaissance/botox-neuromodulator-study.webp", "_source": { "name": "PubMed - Aesthetic Surgery Journal", "url": "https://pubmed.ncbi.nlm.nih.gov/42495855/" } }, { "id": "https://myfacesurgeon.com/compare/facelift-vs-neck-lift", "url": "https://myfacesurgeon.com/compare/facelift-vs-neck-lift", "title": "Facelift vs. Neck Lift", "summary": "This comparison exists because lower-face descent and neck laxity often appear together, yet a focused neck operation and a seamless facelift do not address the same anatomy. The useful question is not which operation is larger; it is which tissue layer and region are actually responsible for the change a patient sees.", "content_text": "This comparison exists because lower-face descent and neck laxity often appear together, yet a focused neck operation and a seamless facelift do not address the same anatomy. The useful question is not which operation is larger; it is which tissue layer and region are actually responsible for the change a patient sees.\n\nThe published facelift approach already considers the face, jowls and neck together when those regions have descended as one system. A separate neck maneuver, fat treatment or platysma work may be incorporated only when it improves overall balance; combining procedures is not automatic.\n\nSurface texture, isolated eyelid hooding, a small fat deposit with resilient skin, or limited muscle banding may be better served by skin care, eyelid surgery, liposculpture or platysmoplasty rather than either broad operation.\n\nThe appropriate choice depends on an examination of the tissue layer creating the concern, the health history, function, goals, tolerance for recovery and reasonable alternatives. Candidacy and planning require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "comparison", "facelift vs neck lift", "Seamless Facelift", "Neck Lift" ], "category": "Decision comparison" }, { "id": "https://myfacesurgeon.com/compare/botox-vs-daxxify", "url": "https://myfacesurgeon.com/compare/botox-vs-daxxify", "title": "BOTOX® Cosmetic vs. DAXXIFY®", "summary": "This comparison exists because both products temporarily reduce selected muscle activity, yet their formulations, units and maintenance rhythms are not interchangeable. The decision should begin with the expression pattern and the value a patient places on flexibility versus a potentially longer studied interval. Product familiarity is not a substitute for checking contraindications, prior response and the exact region being treated.", "content_text": "This comparison exists because both products temporarily reduce selected muscle activity, yet their formulations, units and maintenance rhythms are not interchangeable. The decision should begin with the expression pattern and the value a patient places on flexibility versus a potentially longer studied interval. Product familiarity is not a substitute for checking contraindications, prior response and the exact region being treated.\n\nThe two products are alternatives within the same prescription toxin class, not ingredients to blend casually in one treatment map. Future visits can reconsider product choice after the individual response is understood.\n\nA line caused mainly by lost volume, skin quality or tissue descent may point toward filler, skin treatment or surgery instead of escalating neuromodulator dose or duration.\n\nThe appropriate choice depends on an examination of the tissue layer creating the concern, the health history, function, goals, tolerance for recovery and reasonable alternatives. Candidacy and planning require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "comparison", "Botox vs Daxxify", "BOTOX® Cosmetic", "DAXXIFY®" ], "category": "Decision comparison" }, { "id": "https://myfacesurgeon.com/compare/filler-vs-fat-transfer", "url": "https://myfacesurgeon.com/compare/filler-vs-fat-transfer", "title": "Dermal Filler vs. Facial Fat Transfer", "summary": "This page exists because filler and fat transfer can both contribute volume, but they begin with different materials, different treatment settings and different kinds of uncertainty. Comparing them by syringe count alone misses donor-site planning, tissue behavior, reversibility and the scale of the correction.", "content_text": "This page exists because filler and fat transfer can both contribute volume, but they begin with different materials, different treatment settings and different kinds of uncertainty. Comparing them by syringe count alone misses donor-site planning, tissue behavior, reversibility and the scale of the correction.\n\nA staged plan may use fat for broader continuity and a carefully selected filler for a focal contour, but only when each material has a distinct anatomical job. More product is not automatically more harmonious.\n\nIf descended tissue rather than missing volume creates the concern, adding filler or fat may not solve the structural problem. A facelift, focused lift or observation may be more coherent.\n\nThe appropriate choice depends on an examination of the tissue layer creating the concern, the health history, function, goals, tolerance for recovery and reasonable alternatives. Candidacy and planning require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "comparison", "filler vs fat transfer", "Hyaluronic-acid filler", "Facial fat transfer" ], "category": "Decision comparison" }, { "id": "https://myfacesurgeon.com/compare/lip-lift-vs-lip-filler", "url": "https://myfacesurgeon.com/compare/lip-lift-vs-lip-filler", "title": "Lip Lift vs. Lip Filler", "summary": "This comparison exists because a lip can appear small for more than one reason. A long visible distance beneath the nose, limited pink-lip show and limited tooth show describe a position problem; a desire for shape or volume may describe a filler problem. Treating one as the other can distort proportion. The smile must remain central to planning.", "content_text": "This comparison exists because a lip can appear small for more than one reason. A long visible distance beneath the nose, limited pink-lip show and limited tooth show describe a position problem; a desire for shape or volume may describe a filler problem. Treating one as the other can distort proportion. The smile must remain central to planning.\n\nSome patients may eventually benefit from a staged combination, but the lip position should be understood before adding volume. Existing filler may need time, observation or reduction before surgical planning.\n\nDental position, bite, perioral skin quality, muscle activity or a focal asymmetry can create concerns that neither a lip lift nor more filler fully addresses.\n\nThe appropriate choice depends on an examination of the tissue layer creating the concern, the health history, function, goals, tolerance for recovery and reasonable alternatives. Candidacy and planning require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "comparison", "lip lift vs lip filler", "Lip lift", "Lip filler" ], "category": "Decision comparison" }, { "id": "https://myfacesurgeon.com/compare/sculptra-vs-filler", "url": "https://myfacesurgeon.com/compare/sculptra-vs-filler", "title": "Sculptra® vs. Dermal Filler", "summary": "This comparison exists because “injectable volume” can mean immediate gel support or a gradual collagen-stimulating plan. The treatments differ in material, pace, adjustability, suitable areas and how an early result should be interpreted. A temporary swollen appearance after injection should not be confused with mature collagen response or a settled gel contour. The consultation should also identify whether the concern is truly missing support, because neither material repositions substantially descended tissue or replaces a muscle-directed treatment.", "content_text": "This comparison exists because “injectable volume” can mean immediate gel support or a gradual collagen-stimulating plan. The treatments differ in material, pace, adjustability, suitable areas and how an early result should be interpreted. A temporary swollen appearance after injection should not be confused with mature collagen response or a settled gel contour. The consultation should also identify whether the concern is truly missing support, because neither material repositions substantially descended tissue or replaces a muscle-directed treatment.\n\nA staged plan can assign broader collagen support to Sculptra® and a distinct focal contour to HA filler. The sequence, areas and total product must remain conservative and anatomy-led.\n\nProminent tissue descent, a muscle-led expression line or a surface skin concern may point toward surgery, neuromodulator or skin treatment instead of either volume strategy.\n\nThe appropriate choice depends on an examination of the tissue layer creating the concern, the health history, function, goals, tolerance for recovery and reasonable alternatives. Candidacy and planning require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "comparison", "Sculptra vs filler", "Sculptra®", "Hyaluronic-acid filler" ], "category": "Decision comparison" }, { "id": "https://myfacesurgeon.com/compare/brow-lift-vs-eyelid-lift", "url": "https://myfacesurgeon.com/compare/brow-lift-vs-eyelid-lift", "title": "Brow Lift vs. Eyelid Lift", "summary": "This comparison exists because upper-face heaviness may begin at the brow, within the eyelid or at both levels. Removing eyelid skin when the brow is the main source, or lifting the brow when lid anatomy is the main issue, can answer the wrong question. Dry-eye health, hairline position and natural asymmetry also influence which recovery and scar tradeoffs are reasonable. The safest plan preserves eye function and recognizable expression.", "content_text": "This comparison exists because upper-face heaviness may begin at the brow, within the eyelid or at both levels. Removing eyelid skin when the brow is the main source, or lifting the brow when lid anatomy is the main issue, can answer the wrong question. Dry-eye health, hairline position and natural asymmetry also influence which recovery and scar tradeoffs are reasonable. The safest plan preserves eye function and recognizable expression.\n\nWhen both levels contribute, a conservative combined plan may address brow position and eyelid tissue without asking either operation to overcorrect the other. Combination is based on examination, not a standard package.\n\nDry-eye treatment, allergy care, neuromodulator brow shaping, resurfacing or observation may better fit a functional or skin-quality concern that surgery would not directly solve.\n\nThe appropriate choice depends on an examination of the tissue layer creating the concern, the health history, function, goals, tolerance for recovery and reasonable alternatives. Candidacy and planning require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "comparison", "brow lift vs eyelid lift", "Brow lift", "Eyelid lift" ], "category": "Decision comparison" }, { "id": "https://myfacesurgeon.com/compare/surgical-vs-nonsurgical-rejuvenation", "url": "https://myfacesurgeon.com/compare/surgical-vs-nonsurgical-rejuvenation", "title": "Surgical vs. Non-Surgical Facial Rejuvenation", "summary": "This comparison exists because “facial rejuvenation” is not one diagnosis. Surgery, neuromodulators, fillers, biostimulators and skin treatments work at different anatomical levels. Choosing by downtime alone can lead to repeated treatment of the wrong layer.", "content_text": "This comparison exists because “facial rejuvenation” is not one diagnosis. Surgery, neuromodulators, fillers, biostimulators and skin treatments work at different anatomical levels. Choosing by downtime alone can lead to repeated treatment of the wrong layer.\n\nSurgery and non-surgical care can be complementary when each has a separate job—for example, structural repositioning followed later by selected movement or skin-quality care. Timing follows healing and examination.\n\nA focused eyelid, neck, lip, nose or scar procedure may fit better than a broad facelift, while observation and skin care remain reasonable alternatives for limited concerns.\n\nThe appropriate choice depends on an examination of the tissue layer creating the concern, the health history, function, goals, tolerance for recovery and reasonable alternatives. Candidacy and planning require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "comparison", "surgical vs nonsurgical facial rejuvenation", "Surgical rejuvenation", "Non-surgical rejuvenation" ], "category": "Decision comparison" }, { "id": "https://myfacesurgeon.com/guides/cost-of-facelift-nyc", "url": "https://myfacesurgeon.com/guides/cost-of-facelift-nyc", "title": "Cost of a Facelift in NYC", "summary": "What changes a New York facelift quotation, what the written quote should include, and why the final figure follows an examination rather than an online price range.", "content_text": "This guide exists to help a patient understand a facelift quotation without publishing a number that pretends every operation is the same. The useful comparison is a complete, anatomy-specific plan—not a headline figure detached from surgical scope, setting, anesthesia, follow-up and revision terms.\n\nWhy one facelift price cannot describe every plan\n\nThe published Seamless Facelift dossier treats facial aging as a three-dimensional change involving skin, retaining ligaments, fat compartments and deeper support. One patient may have connected cheek, jowl, jawline and neck descent. Another may have an isolated neck concern, eyelid hooding or surface skin change that does not call for the same operation. A single online range hides that diagnostic difference and can make a smaller or larger procedure sound interchangeable when it is not.\n\nA responsible quotation therefore begins only after the anatomy has been examined and the intended operation has been named. It should be possible to understand whether the plan is a facelift alone, a connected face-and-neck operation, or a focused alternative. The quotation is not evidence of candidacy, and a lower or higher figure does not establish that the proposed scope is correct.\n\nSurgical scope and technique\n\nThe site describes concealed incision mapping, multi-vector repositioning of deeper tissue, coordinated treatment of the lower face and neck, careful skin redraping and a buried closure when clinically appropriate. The time and resources required depend on which of those steps are actually indicated. Selected patients may also discuss neck work, fat transfer or eyelid treatment, but combination is appropriate only when it improves facial balance rather than simply adding procedures.\n\nAsk the quotation to use precise procedure names. “Facial rejuvenation” is too broad to reveal what is being performed. A patient should know which regions are included, which are not, whether any adjunct is optional, and whether postoperative visits described by the practice are included. This makes two proposals easier to compare without assuming that similar titles represent the same work.\n\nSurgeon, anesthesia and facility\n\nThe practice’s financing page explains that professional, facility, anesthesia and follow-up fees depend on the individual plan. These are separate categories even when presented as one total. Anesthesia may involve local anesthesia, local anesthesia with sedation or general anesthesia depending on the procedure, duration, health history and surgical setting. The surgeon and anesthesia team explain the recommended approach and its risks before surgery.\n\nA written quotation should identify whether the surgeon’s professional service, the operating facility and the anesthesia service are included. It should also explain which preoperative or follow-up items are part of the plan and which could be billed separately. That level of clarity is more useful than comparing an advertised surgical fee with a complete all-category quotation.\n\nComplexity, prior surgery and revision policy\n\nPrior facial operations, scars, asymmetry, healing history and the need to coordinate several anatomical layers may change planning. The site does not promise a particular result or a no-cost revision. It states that a revision cannot be judged until healing is sufficiently mature and that any persistent concern requires review of the anatomy, photographs, healing course, original plan and reasonable alternatives.\n\nBefore scheduling, ask how the practice handles a concern that remains after adequate healing. The policy should distinguish professional fees, facility fees and anesthesia costs without suggesting that revision is automatic. A transparent policy does not guarantee that another operation will be appropriate; it explains how the question will be evaluated.\n\nWhat the personalized quote should itemize\n\nThe clearest quotation is written, procedure-specific and time-limited. It should connect the financial document to the same clinical plan discussed in consultation. If a neck procedure, fat transfer, eyelid treatment or another adjunct is considered, the patient should be able to see whether it is included, separately priced or deferred. The quote should also make payment timing and cancellation or rescheduling terms understandable before a commitment is made.\n\nThe exact operation and anatomical regions included.\n\nProfessional, facility and anesthesia categories.\n\nIncluded preoperative and postoperative services.\n\nOptional or staged procedures shown separately.\n\nHow long the quotation remains current.\n\nThe process for discussing a concern after healing.\n\nFinancing without letting financing choose the operation\n\nThird-party healthcare financing may be available for qualified applicants. The existing site is explicit that financing is a loan rather than a discount and that approval, interest, repayment terms and fees are controlled by the lender. The practice cannot promise approval or lender terms. A patient should receive the clinical plan and full quotation before evaluating a financing offer.\n\nApproval should never determine candidacy, surgical timing or scope. The sequence is anatomy and goals first, reasonable options and risks second, then a written quotation and payment decision. A consultation is the point at which the practice can explain the personalized plan; this guide cannot estimate an individual total.\n\nDagan MD does not use a universal online figure because the operation, anesthesia, facility and follow-up depend on the anatomy and selected scope. A written personalized quotation is provided after consultation and should identify each included category. Candidacy, the treatment plan and a personalized quotation require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "cost", "cost of facelift NYC", "Minimally Invasive Seamless Facelift" ], "image": "https://myfacesurgeon.com/images/facelift-before-after-profile.webp", "category": "Cost guide" }, { "id": "https://myfacesurgeon.com/guides/cost-of-rhinoplasty-nyc", "url": "https://myfacesurgeon.com/guides/cost-of-rhinoplasty-nyc", "title": "Cost of Rhinoplasty in NYC", "summary": "The anatomical, functional, technical and setting-related factors that shape a New York rhinoplasty quotation—and the questions a complete quote should answer.", "content_text": "This guide exists because a cosmetic bridge refinement, a functional airway operation and a revision rhinoplasty are not financially or surgically equivalent. It helps a patient ask whether the quotation matches the exact external and internal work being proposed, without substituting an online number for examination.\n\nThe word rhinoplasty can describe different operations\n\nThe published rhinoplasty dossier evaluates the skin envelope, nasal bones, upper and lower lateral cartilages, septum, nasal valves, turbinates and the nose’s relationship to the entire face. A plan may address appearance, breathing or both. The external shape alone does not reveal whether the septum, valve support or turbinates require treatment, and a cosmetic concern does not automatically justify a functional procedure.\n\nBecause scope varies, an online range cannot show whether two quotations describe the same operation. A responsible proposal should distinguish primary from revision surgery, cosmetic work from medically indicated airway work, and an external reshaping plan from septoplasty or conservative turbinate reduction. The quotation should follow the examination that establishes those indications.\n\nFunctional work must have an indication\n\nThe site states that septoplasty is added only when a deviated septum contributes to obstruction, limits surgical access or is needed for structural support. Conservative turbinate treatment is considered when examination identifies persistent enlargement and a functional reason to create more space while preserving the lining that warms and humidifies air. These are not automatic line items for every rhinoplasty.\n\nIf functional work is proposed, ask the quotation to identify it separately and ask the clinical discussion to explain the finding. Insurance eligibility, authorization, deductibles and network rules are determined by the plan, and the practice cannot guarantee payment. Cosmetic and functional portions may be handled differently, so financial paperwork should never blur the medical indication.\n\nPrimary, revision and structural complexity\n\nA first operation and a revision may require different access, grafting and scar management. The dossier describes open or endonasal access, preservation or reshaping of the bridge and tip, and septal, ear or rib cartilage grafting when support is needed. Prior surgery can change available cartilage, internal scarring and the reliability of familiar tissue planes.\n\nComplexity is not a promise of a better result, and technology does not eliminate risk. The site describes controlled bone refinement with a Piezotome and fine rasping when indicated, while still disclosing bruising, swelling, asymmetry, breathing problems, contour irregularity and possible revision. A quotation should reflect the selected plan without turning a device name into a marketing surcharge.\n\nAnesthesia, facility and postoperative care\n\nAnesthesia depends on the operation, duration, health history and surgical setting. The financing resource asks patients to identify professional, facility, anesthesia and follow-up fees. Rhinoplasty follow-up may include early splint or silicone septal-splint management, gentle removal of remaining absorbable material when used, airway assessment and longer observation as swelling and definition evolve.\n\nThe quote should state whether these categories are included and how postoperative visits are handled. It should also distinguish expected routine follow-up from an unplanned service or later revision discussion. A low headline fee that omits the facility or anesthesia category cannot be compared directly with a complete quotation.\n\nWhat a clear rhinoplasty quotation should show\n\nThe written document should mirror the surgical conversation. If a step is being considered but not yet confirmed, that uncertainty should be visible rather than hidden inside a vague package. The patient should understand what is cosmetic, what is functional, which graft source is anticipated if any, and whether additional testing or coordination remains to be completed.\n\nPrimary or revision rhinoplasty status.\n\nExternal cosmetic work and internally indicated functional work.\n\nSeptoplasty, nasal-valve support or turbinate treatment when indicated.\n\nAnticipated cartilage graft source when relevant.\n\nProfessional, facility, anesthesia and follow-up categories.\n\nInsurance and self-pay portions kept clearly separate.\n\nFinancing and the consultation sequence\n\nThird-party financing may be available, but the lender controls approval, interest, fees and repayment terms. The practice’s published policy is that the treatment plan comes before the payment plan. A financing approval cannot establish that septoplasty, grafting, a revision approach or cosmetic reshaping is appropriate.\n\nConsultation should produce the anatomical explanation, alternatives, recovery discussion and written quotation needed to make a financial decision. It may begin virtually, but surgery and functional planning require an in-person examination. This page intentionally provides no invented number because it cannot know the work an individual nose requires.\n\nThe total depends on whether the plan is primary or revision surgery, cosmetic or functional, the structural work required, anesthesia, facility and follow-up. Dagan MD provides a written personalized quotation after the necessary examination rather than a universal online number. Candidacy, the treatment plan and a personalized quotation require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "cost", "cost of rhinoplasty NYC", "Rhinoplasty" ], "image": "https://myfacesurgeon.com/images/procedures/rhinoplasty.webp", "category": "Cost guide" }, { "id": "https://myfacesurgeon.com/guides/cost-of-botox-nyc", "url": "https://myfacesurgeon.com/guides/cost-of-botox-nyc", "title": "Cost of BOTOX® Cosmetic in NYC", "summary": "What makes a New York neuromodulator quotation meaningful, including product identity, treatment map, maintenance and the difference between BOTOX® Cosmetic and DAXXIFY®.", "content_text": "This guide exists because a neuromodulator quote only makes sense when it identifies the product, the muscles and regions being considered, and the clinical goal. Comparing an isolated advertised figure without those details can reward undertreatment, overtreatment or an entirely different product.\n\nA quote should begin with the expression pattern\n\nThe published BOTOX® Cosmetic page describes measured treatment of selected muscle activity in the forehead, frown area and crow’s-feet region while retaining recognizable movement. The dose and placement are tailored to anatomy, expression and goals rather than a fixed injection map. That means the financial discussion cannot be separated from which muscles are being treated and what balance must be preserved.\n\nA headline amount does not explain whether it covers one limited area or several interacting regions. It also does not reveal whether the plan is conservative by design, incomplete, or larger than the patient needs. The quotation should identify the intended regions and product while leaving dose as a medical decision.\n\nProduct identity matters\n\nBOTOX® Cosmetic, DAXXIFY®, Dysport and Xeomin belong to the same prescription toxin class, but their units cannot be converted directly and their formulations and studied maintenance rhythms differ. The site describes BOTOX® Cosmetic around an up-to-four-month interval and DAXXIFY® around six months while repeatedly emphasizing individual variation.\n\nA comparison based only on the price of a unit can therefore be misleading when the units are product-specific. The quotation should name the product rather than use “Botox” as a generic word for every neuromodulator. A longer studied interval may be attractive to one patient, while another may value the flexibility of a shorter-acting choice.\n\nDose is not a retail quantity\n\nDose depends on muscle strength, asymmetry, prior response, neighboring muscle balance and the desired preservation of expression. More is not automatically better, and less is not automatically more natural if it fails to address the agreed concern. The treating clinician should explain the plan without promising exact symmetry, duration or a particular appearance.\n\nAsk whether the quote reflects the proposed treatment map and whether reassessment after onset is part of the plan. The site describes conservative, anatomy-led dosing and future adjustment based on individual response. It does not support choosing a dose because a promotion makes a larger amount financially tempting.\n\nClinical evaluation and who performs treatment\n\nNeuromodulators are prescription medicines with contraindications and potential adverse effects. The site advises patients to confirm which appropriately licensed clinician will evaluate and perform treatment. Product identity and the treating clinician should be clear before injection.\n\nThe quotation should not erase the medical visit. It should be possible to understand whether evaluation, treatment and ordinary follow-up are included. If another concern—volume loss, skin quality or tissue descent—is responsible for the line, the best financial decision may be not to purchase more neuromodulator.\n\nWhat to ask before comparing BOTOX® quotations\n\nA transparent comparison uses the same clinical scope on both sides. Ask these questions before deciding that one advertised offer is less expensive. The answers do not establish candidacy, but they reveal whether the proposals describe the same product and treatment goal.\n\nWhich prescription neuromodulator is being quoted?\n\nWhich muscle groups or facial regions are included?\n\nWho evaluates and performs the treatment?\n\nHow is asymmetry and prior response considered?\n\nIs a post-onset reassessment included when appropriate?\n\nWhat maintenance rhythm is being discussed without promising duration?\n\nMaintenance, promotions and financial restraint\n\nThe cost of a temporary treatment includes the maintenance rhythm the patient chooses after seeing an individual response. BOTOX® Cosmetic and DAXXIFY® may lead to different intervals, but neither guarantees that one person will match an advertised study window. An unwanted effect may also last until the medicine wears off.\n\nA promotion should never determine dose, timing, product or candidacy. The existing site’s loyalty language keeps those choices medical. Consultation establishes whether the concern is movement-led and whether a neuromodulator is reasonable; the personalized treatment quotation follows that evaluation.\n\nThe meaningful quotation depends on the named prescription product, the treatment regions, anatomy-led dose, treating clinician and follow-up plan. Product units are not interchangeable, so an isolated advertised figure may not describe the same treatment. Candidacy, the treatment plan and a personalized quotation require consultation.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "cost", "cost of Botox NYC", "BOTOX® Cosmetic" ], "image": "https://myfacesurgeon.com/images/procedures/botox-cosmetic.webp", "category": "Cost guide" }, { "id": "https://myfacesurgeon.com/guides/facelift-recovery-time", "url": "https://myfacesurgeon.com/guides/facelift-recovery-time", "title": "Facelift Recovery Time", "summary": "A conservative week-by-week framework for understanding early swelling, bruising, sensation, firmness, scar maturation and the questions to personalize before a seamless facelift.", "content_text": "This guide exists to separate early social recovery from deeper healing. A patient may look more presentable before sensation, firmness, scars and internal contour have finished changing. The sequence below organizes the published facelift recovery language without promising the date any individual will be ready for work, travel or an event.\n\nBefore surgery: define what “recovered” means\n\nThe Seamless Facelift dossier describes connected treatment of the cheek, jowls, jawline and neck, with deeper support repositioned and skin redraped without relying on surface tension. Recovery therefore has several clocks: bruising and visible swelling, comfort and energy, sensation and firmness, incision maturation, return to activity, and the much later judgment of contour.\n\nBefore selecting a date, ask the practice to translate those clocks into work duties, caregiving, travel and privacy preferences. Arrange transportation and the recommended help at home, review medications, supplements and nicotine use, and follow the individualized fasting and medication instructions. A website timeline cannot replace the written plan.\n\nWeek one: early healing is not the result\n\nThe first week belongs to protection, rest, incision care and follow-up. Swelling and bruising are expected to be most visible early. Tightness, temporary numbness and asymmetry can reflect swelling and the different pace at which tissues settle. The face should not be judged against a final photograph during this phase.\n\nDressings, washing, medication and sleeping position must follow the instructions supplied for the actual operation. The site intentionally avoids a universal promise about pain, appearance or independence because a face-only plan and a connected face-and-neck plan may not feel the same. Direct practice guidance overrides this narrative.\n\nWeek two: outward improvement may outpace internal settling\n\nBruising and swelling often continue improving in stages, but the published dossier warns that sensation, firmness and subtle asymmetry may evolve for weeks to months. A person may feel ready for a quiet routine before feeling comfortable with close social scrutiny, prolonged activity or travel. Work demands and how private someone wants early healing to remain matter.\n\nThis is a useful point to ask what makeup, skin products, glasses, hair styling and incision exposure are permitted. Those answers depend on healing and should not be assumed. A calendar event should never pressure a patient to conceal a problem or ignore a restriction.\n\nWeeks three through six: function returns before maturation ends\n\nAs visible changes become less prominent, deeper firmness, altered sensation and small contour differences can remain. Activity should progress only as the surgeon allows. The relevant question is not whether a generic patient can exercise at a certain week; it is whether the actual incisions, swelling, blood pressure considerations and combined procedures support that step.\n\nThis phase can also create impatience because the operation is no longer new but the face is not fully settled. The site’s medical-restraint language matters here: early swelling, firmness or asymmetry should not be mistaken for the final contour, and no technique can guarantee a particular result.\n\nFollowing months: scars, sensation and contour continue to mature\n\nIncisions are planned within natural ear contours, folds and relaxed skin-tension lines, and a buried closure may be used when appropriate. “Seamless” describes that planning philosophy, not an invisible scar. Scar color, width and visibility depend on anatomy, tension, aftercare and individual healing. Contour refinement and sensation can continue beyond the social-recovery period.\n\nFollow-up remains part of recovery even when daily life feels normal. A concern about scar behavior, asymmetry, firmness or contour should be assessed in the context of healing time rather than compared with a fixed online deadline. Revision is never automatic and cannot be evaluated before tissues are sufficiently mature.\n\nPlan an occasion with ranges, not a promise\n\nUse the Occasion Planner to list the date, travel, photography, physical demands and how much visible healing would feel acceptable. Then bring that plan to consultation. The Recovery Companion can organize general postoperative stages after a procedure is confirmed, but written instructions and Dr. Dagan’s direction always override it.\n\nRisks including bleeding, infection, delayed healing, skin loss, contour irregularity, nerve weakness and unfavorable scars can change the expected course. A website cannot decide whether a symptom is routine. Follow the practice’s urgent-contact directions and seek direct assessment when instructed.\n\nVisible swelling and bruising improve in stages, while sensation, firmness, subtle asymmetry, scars and contour may continue changing for weeks to months. Work, travel, exercise and event timing depend on the operation and individual healing. Recovery guidance must be individualized after examination and a confirmed procedure. Written postoperative instructions and direct guidance from the practice always take priority.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "recovery", "facelift recovery time", "Minimally Invasive Seamless Facelift" ], "image": "https://myfacesurgeon.com/images/facelift-before-after-profile.webp", "category": "Recovery guide" }, { "id": "https://myfacesurgeon.com/guides/rhinoplasty-recovery-time", "url": "https://myfacesurgeon.com/guides/rhinoplasty-recovery-time", "title": "Rhinoplasty Recovery Time", "summary": "A conservative week-by-week account of splint care, congestion, bruising, swelling, activity restrictions, airway healing and the long refinement period after rhinoplasty.", "content_text": "This guide exists because the removal of a splint is not the end of rhinoplasty recovery. Bruising, congestion and visible swelling often improve much earlier than tip definition, internal airway settling and the final interpretation of contour. The timeline is a framework for questions, not a personal clearance schedule.\n\nBefore surgery: know whether the plan is cosmetic, functional or both\n\nRhinoplasty planning includes the skin envelope, nasal bones, cartilages, septum, valves, turbinates and the nose’s relationship to the face. Recovery questions depend on which of those structures are treated. A cosmetic change does not automatically include septoplasty or turbinate reduction, and an airway operation may introduce internal splints or absorbable material not used in every case.\n\nReview medications, supplements, nicotine use, health history and the individualized fasting instructions. Arrange transportation and the recommended help. Ask which external splint, internal silicone splint or absorbable bleeding-control material is anticipated, how follow-up is scheduled and which symptoms require direct contact.\n\nWeek one: splint, congestion and visible early change\n\nThe published dossier states that an external splint is commonly used during the first week and that congestion, bruising and swelling are expected. If septoplasty is performed, soft silicone splints may support alignment, reduce the chance of blood collecting between tissue layers and discourage internal adhesions. They are different from traditional non-absorbable packing.\n\nWhen bleeding control is needed, Dr. Dagan may use an absorbable gelatin-and-thrombin material designed to break down, with a small remainder gently suctioned at follow-up. The exact materials and removal plan belong in the written instructions. The appearance beneath a splint is not a final contour.\n\nWeek two: the public face and the healing nose are different\n\nAfter the earliest dressings or splints are addressed, bruising may be less visible while swelling remains. Nasal skin thickness, tip work, bone work and prior surgery can change what is noticeable. The site makes no promise that a patient will feel socially ready at a specific date.\n\nBreathing may also feel different while internal tissues remain swollen. A straighter septum illustration is educational, not a guarantee of immediate airflow. Allergy, inflammation, valve behavior and turbinate tissue can influence the experience, and persistent obstruction requires examination rather than self-diagnosis.\n\nWeeks three through six: protect the structure while routine returns\n\nThe published recovery guidance restricts contact sports, pressure on the bridge and unapproved nasal medications during early healing. Glasses, exercise, travel and any activity that risks impact should be discussed for the actual operation. Feeling more comfortable does not mean nasal bones, cartilage support and internal lining are ready for unrestricted pressure.\n\nPlasma-assisted preparation, piezoelectric bone sculpting and fine rasping are described as controlled techniques, but no device eliminates bruising, swelling or contour risk. Technology does not shorten every person’s timeline to the same calendar.\n\nFollowing months and beyond: definition is gradual\n\nMost visible swelling improves gradually, while the site states that tip definition may continue changing for a year or longer. That does not mean every patient looks obviously swollen for that entire period. It means early photographs and impressions should not be treated as the final result, particularly after tip work or revision surgery.\n\nSmall differences in firmness, sensation and contour can evolve. Follow-up allows the surgeon to interpret those changes in the context of the operation. Dissatisfaction or a visible irregularity cannot be responsibly converted into a revision plan before healing is sufficiently mature.\n\nUse planning tools without turning them into clearance\n\nThe Occasion Planner helps identify travel, photography, public speaking, exercise and privacy needs surrounding an important date. Bring that worksheet to consultation so the practice can discuss whether the proposed interval is realistic. The Recovery Companion can organize general stages after the plan is confirmed and stays subordinate to written instructions.\n\nRhinoplasty risks include bleeding, infection, breathing difficulty, septal perforation, smell change, valve compromise, asymmetry, contour irregularity and possible revision. A web page cannot decide whether a symptom is expected. Use the practice’s direct and urgent pathways according to the postoperative instructions.\n\nA splint is commonly used during the first week, and bruising, congestion and swelling improve gradually. The public-facing recovery period is shorter than the full refinement period; tip definition may continue changing for a year or longer. Recovery guidance must be individualized after examination and a confirmed procedure. Written postoperative instructions and direct guidance from the practice always take priority.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "recovery", "rhinoplasty recovery time", "Rhinoplasty" ], "image": "https://myfacesurgeon.com/images/procedures/rhinoplasty.webp", "category": "Recovery guide" }, { "id": "https://myfacesurgeon.com/guides/eyelid-lift-recovery-time", "url": "https://myfacesurgeon.com/guides/eyelid-lift-recovery-time", "title": "Eyelid Lift Recovery Time", "summary": "A week-by-week framework for bruising, swelling, prescribed eye care, dryness, light sensitivity, incision maturation and functional monitoring after blepharoplasty.", "content_text": "This guide exists because eyelid recovery is not measured only by bruising. Dryness, light sensitivity, lid closure, incision maturation and the relationship between the eyelid and brow can matter after the most visible color changes have improved. The stages below are conservative questions to personalize.\n\nBefore surgery: recovery planning begins with eye health\n\nUpper and lower eyelid planning considers skin, muscle, fat, tendon support, eye prominence, brow position and the tear film. Recovery therefore depends on whether the operation is upper, lower or combined and whether dry eye, allergy, lid support or a brow concern changes the plan. Skin excess alone is not the complete diagnosis.\n\nReview medications, supplements, health history and nicotine use, arrange transportation and follow the individualized fasting and medication instructions. Ask which drops, ointment, cold compress routine and head-elevation plan will be prescribed. Existing eye symptoms should be discussed before surgery rather than assumed to be part of ordinary recovery.\n\nWeek one: protect the eye surface and watch function\n\nThe published dossier emphasizes cold compresses, head elevation and prescribed eye care early. Bruising, swelling, dryness and light sensitivity can occur. The eyelid may feel tight or look uneven while swelling changes, and an early mirror view should not be interpreted as the mature lid position.\n\nVision-threatening bleeding is described as very rare but urgent. The website cannot triage symptoms or replace the postoperative contact plan. Patients should know how to reach the practice, when the written instructions direct immediate contact and when emergency evaluation is required.\n\nWeek two: visible color may improve before comfort normalizes\n\nBruising and swelling usually improve in stages, but dryness, light sensitivity and awareness of the incisions may persist. Screen use, reading, contact lenses, makeup and return to public work are individual questions. The correct answer depends on eye comfort, closure, visual demands and the actual operation.\n\nSomeone with a physically quiet job may have a different practical threshold from someone working in bright light, prolonged screen conditions or a visually public role. The site therefore avoids a fixed return-to-work promise and recommends a personalized range.\n\nWeeks three through six: the eyelid-brow relationship settles\n\nAs swelling recedes, the relationship among brow position, upper-lid fold and lower-lid support becomes easier to interpret. A brow lift and eyelid lift treat different anatomical levels, and residual upper-face heaviness should not automatically be labeled insufficient eyelid skin removal.\n\nActivity progression, eye products and scar care follow the surgeon’s instructions. Dry eye, blurred or double vision, difficulty closing the eyes, lid malposition and asymmetry are among the published risks and deserve direct evaluation rather than online comparison.\n\nFollowing months: incisions and subtle contours mature\n\nThe dossier states that incisions and subtle contour changes continue maturing for months. Scar color and firmness can change after a person has returned to normal routines. Lower-lid position and the lid-cheek transition may also require time before a responsible judgment can be made.\n\nFollow-up helps distinguish normal maturation from a concern requiring care. Surgery cannot guarantee perfect symmetry, eliminate every line or prevent future aging. Revision cannot be assumed before the tissues and eye function have been adequately assessed over time.\n\nPlan photography, travel and work with clinical context\n\nUse the Occasion Planner to note photography, lighting, screen work, contact-lens needs, travel and how much visible bruising would feel acceptable. Bring those priorities to consultation. The Recovery Companion can help organize general day-by-day questions after surgery, but the individual eye-care plan remains the authority.\n\nAlternatives may include observation, dry-eye or allergy treatment, brow lift when brow descent is primary, neuromodulator, resurfacing or selected filler. Understanding those alternatives is part of recovery planning because the right operation is the first safeguard against an avoidable or mismatched recovery.\n\nBruising, swelling, dryness and light sensitivity improve in stages, while incisions and subtle contour changes continue maturing for months. Return to work, lenses, makeup, exercise and travel depend on eye comfort, function and the operation performed. Recovery guidance must be individualized after examination and a confirmed procedure. Written postoperative instructions and direct guidance from the practice always take priority.", "date_published": "2026-07-24T12:00:00Z", "date_modified": "2026-07-24T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "recovery", "eyelid lift recovery time", "Eyelid Lift (Blepharoplasty)" ], "image": "https://myfacesurgeon.com/images/procedures/eyelid-lift.webp", "category": "Recovery guide" }, { "id": "https://myfacesurgeon.com/trends/picosecond-laser-skincare-photoaging-2026", "url": "https://myfacesurgeon.com/trends/picosecond-laser-skincare-photoaging-2026", "title": "A split-face trial suggests adjunct skincare may improve some picosecond-laser photoaging outcomes.", "summary": "In a randomized evaluator-blinded split-face study published July 23, 2026, a 755-nm picosecond alexandrite laser improved photoaging measures, and the side assigned to a branded adjunct skincare regimen showed greater wrinkle and texture gains. It is useful signal-level evidence for peri-procedure skin support, but the single-center design, photoaging focus and company-linked regimen mean clinicians should avoid treating one post-laser routine as universally superior.", "content_text": "In a randomized evaluator-blinded split-face study published July 23, 2026, a 755-nm picosecond alexandrite laser improved photoaging measures, and the side assigned to a branded adjunct skincare regimen showed greater wrinkle and texture gains. It is useful signal-level evidence for peri-procedure skin support, but the single-center design, photoaging focus and company-linked regimen mean clinicians should avoid treating one post-laser routine as universally superior.\n\nSource lens: Randomized split-face trial - Adjunct skincare was brand-specific and the study population was limited\n\nPRP + Microneedling: Compare collagen-focused skin remodeling with other texture and tone strategies that may involve different downtime profiles.\n\nConsultation: Post-procedure skincare still needs to match the device settings, skin type, pigment risk and healing history.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-23T12:00:00Z", "date_modified": "2026-07-28T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "picosecond laser", "photoaging", "post-laser skincare", "split-face trial", "tranexamic acid", "skin barrier" ], "image": "https://myfacesurgeon.com/images/editorial/picosecond-laser-skincare-v1.webp", "_source": { "name": "PubMed - Aesthetic Plastic Surgery", "url": "https://pubmed.ncbi.nlm.nih.gov/42493591/" } }, { "id": "https://myfacesurgeon.com/trends/low-cross-linked-ha-skin-quality-2026", "url": "https://myfacesurgeon.com/trends/low-cross-linked-ha-skin-quality-2026", "title": "Low-cross-linked hyaluronic acid is being studied for fine-line and skin-quality support in delicate facial zones.", "summary": "A 25-patient observational study published July 23, 2026 reported improved periorbital and perioral wrinkle scores, skin-quality measures and ultrasound-based dermal findings after three sessions of low-cross-linked hyaluronic-acid microinjections. The early signal is interesting for thin, mobile facial areas, but the cohort was small, non-comparative and included industry involvement, so it should not be read as a blanket answer for every fine-line concern.", "content_text": "A 25-patient observational study published July 23, 2026 reported improved periorbital and perioral wrinkle scores, skin-quality measures and ultrasound-based dermal findings after three sessions of low-cross-linked hyaluronic-acid microinjections. The early signal is interesting for thin, mobile facial areas, but the cohort was small, non-comparative and included industry involvement, so it should not be read as a blanket answer for every fine-line concern.\n\nSource lens: Observational study - Small cohort, no comparator arm and industry involvement limit generalization\n\nInjectables Reframed: See how skin-quality injectables differ from volume-focused fillers and why tissue behavior matters.\n\nConsultation: Fine lines around the eyes and mouth may call for different combinations of injectables, resurfacing or surgery.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-23T12:00:00Z", "date_modified": "2026-07-28T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "low-cross-linked hyaluronic acid", "skin quality", "periorbital wrinkles", "perioral wrinkles", "microinjections", "Dermatology and Therapy" ], "image": "https://myfacesurgeon.com/images/renaissance/injectables-study.jpg", "_source": { "name": "PubMed - Dermatology and Therapy", "url": "https://pubmed.ncbi.nlm.nih.gov/42487104/" } }, { "id": "https://myfacesurgeon.com/trends/ev-facial-rejuvenation-review-2026", "url": "https://myfacesurgeon.com/trends/ev-facial-rejuvenation-review-2026", "title": "Extracellular-vesicle facial rejuvenation still looks early despite growing regenerative buzz.", "summary": "A systematic review published July 22, 2026 found preliminary signals that extracellular-vesicle therapies may improve wrinkle severity, pigmentation, hydration, elasticity or overall appearance in nonsurgical facial rejuvenation studies. The same review rated the evidence low to very low certainty and noted moderate-to-critical risk of bias, so this remains an emerging regenerative area that needs stronger trials before confident mainstream use.", "content_text": "A systematic review published July 22, 2026 found preliminary signals that extracellular-vesicle therapies may improve wrinkle severity, pigmentation, hydration, elasticity or overall appearance in nonsurgical facial rejuvenation studies. The same review rated the evidence low to very low certainty and noted moderate-to-critical risk of bias, so this remains an emerging regenerative area that needs stronger trials before confident mainstream use.\n\nSource lens: Systematic review - Most included evidence was low certainty with heterogeneous methods and short follow-up\n\nSculptra Rejuvenation: Compare established collagen-stimulation options with earlier-stage regenerative concepts that still need stronger evidence.\n\nPRP + Microneedling: See how blood-derived and device-assisted regenerative strategies differ from extracellular-vesicle claims.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-22T12:00:00Z", "date_modified": "2026-07-28T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "extracellular vesicles", "regenerative aesthetics", "facial rejuvenation", "systematic review", "skin quality", "emerging evidence" ], "image": "https://myfacesurgeon.com/images/renaissance/regenerative-study.webp", "_source": { "name": "PubMed - Facial Plastic Surgery & Aesthetic Medicine", "url": "https://pubmed.ncbi.nlm.nih.gov/42487416/" } }, { "id": "https://myfacesurgeon.com/trends/txa-rhinoplasty-recovery-2026", "url": "https://myfacesurgeon.com/trends/txa-rhinoplasty-recovery-2026", "title": "Topical tranexamic acid may reduce early bruising and swelling after rhinoplasty.", "summary": "In a triple-blind randomized trial of 75 primary open rhinoplasty patients, both topical and injected tranexamic acid outperformed saline for early periorbital edema and ecchymosis, with the topical route performing best through day 3. It is promising postoperative-support data, not a universal recovery instruction, and surgeons still individualize bleeding and clotting precautions.", "content_text": "In a triple-blind randomized trial of 75 primary open rhinoplasty patients, both topical and injected tranexamic acid outperformed saline for early periorbital edema and ecchymosis, with the topical route performing best through day 3. It is promising postoperative-support data, not a universal recovery instruction, and surgeons still individualize bleeding and clotting precautions.\n\nSource lens: Randomized controlled trial · Recovery steps remain surgeon-specific\n\nRhinoplasty: See how structural planning and postoperative recovery are tailored to the actual nasal anatomy and operation.\n\nConsultation: Discuss which recovery-support steps make sense for your health history, medications and surgical plan.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-15T12:00:00Z", "date_modified": "2026-07-21T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "tranexamic acid", "rhinoplasty recovery", "edema", "ecchymosis", "postoperative bruising", "Aesthetic Surgery Journal" ], "image": "https://myfacesurgeon.com/images/editorial/txa-rhinoplasty-recovery-v1.webp", "_source": { "name": "PubMed · Aesthetic Surgery Journal", "url": "https://pubmed.ncbi.nlm.nih.gov/41419221/" } }, { "id": "https://myfacesurgeon.com/trends/alloclae-adipose-allograft-2026", "url": "https://myfacesurgeon.com/trends/alloclae-adipose-allograft-2026", "title": "alloClae brings donor adipose tissue into the body-contouring conversation.", "summary": "alloClae is a ready-to-use human adipose-tissue allograft intended for localized subcutaneous cushioning and support where fat naturally exists. It avoids a fat-harvest procedure, but it is not a synthetic facial filler, does not contain living cells, and carries tissue-product risks that deserve a careful candidacy and consent discussion.", "content_text": "alloClae is a ready-to-use human adipose-tissue allograft intended for localized subcutaneous cushioning and support where fat naturally exists. It avoids a fat-harvest procedure, but it is not a synthetic facial filler, does not contain living cells, and carries tissue-product risks that deserve a careful candidacy and consent discussion.\n\nSource lens: Manufacturer information · Product status, candidacy and risks require clinician review\n\nInjectables Reframed: Compare tissue allografts with hyaluronic-acid fillers, biostimulators and neuromodulators.\n\nFacial Fat Transfer: Understand how a donor-derived product differs from harvesting and transferring your own fat.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-14T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "alloClae", "adipose tissue allograft", "body contouring", "soft tissue support", "donor adipose tissue", "HCT/P" ], "image": "https://myfacesurgeon.com/images/editorial/alloclae-adipose-v1.webp", "_source": { "name": "alloClae · Tiger Aesthetics Medical", "url": "https://alloclae.com/" } }, { "id": "https://myfacesurgeon.com/trends/belotero-intense-lips-fda-2026", "url": "https://myfacesurgeon.com/trends/belotero-intense-lips-fda-2026", "title": "FDA approval adds Belotero Intense (+) Lidocaine to the lip-augmentation lineup.", "summary": "The FDA approved Belotero Intense (+) Lidocaine on July 9, 2026 for submucosal and/or subcutaneous implantation for lip augmentation in adults over 21. Approval confirms an authorized indication and labeling pathway, not that one filler is best for every lip shape, anatomy or risk profile.", "content_text": "The FDA approved Belotero Intense (+) Lidocaine on July 9, 2026 for submucosal and/or subcutaneous implantation for lip augmentation in adults over 21. Approval confirms an authorized indication and labeling pathway, not that one filler is best for every lip shape, anatomy or risk profile.\n\nSource lens: Primary regulatory source · Approval does not establish superiority or candidacy\n\nInjectables Reframed: Compare lip fillers with neuromodulators, skin-quality injectables and structure-first facial planning.\n\nLip Lift: See when shape, show and lip-to-nose proportions may call for surgery instead of more volume.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-09T12:00:00Z", "date_modified": "2026-07-21T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "Belotero Intense", "lip augmentation", "FDA approval", "hyaluronic acid filler", "Merz", "injectables" ], "image": "https://myfacesurgeon.com/images/illustrations/filler-materials-editorial.png", "_source": { "name": "U.S. Food and Drug Administration", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P250016" } }, { "id": "https://myfacesurgeon.com/trends/botulinum-toxin-scar-prevention-2026", "url": "https://myfacesurgeon.com/trends/botulinum-toxin-scar-prevention-2026", "title": "Botulinum toxin is being studied more seriously as an early scar-modulation tool.", "summary": "A 2026 systematic review and meta-analysis pooled 19 studies involving 686 patients and found better scar scores, narrower scars and higher satisfaction with botulinum toxin type A, while also calling for larger, more uniform trials. That makes it an evidence-building option for selected fresh scars rather than a blanket recommendation for every incision.", "content_text": "A 2026 systematic review and meta-analysis pooled 19 studies involving 686 patients and found better scar scores, narrower scars and higher satisfaction with botulinum toxin type A, while also calling for larger, more uniform trials. That makes it an evidence-building option for selected fresh scars rather than a blanket recommendation for every incision.\n\nSource lens: Meta-analysis · Results are encouraging but study designs remain heterogeneous\n\nScar Revision: Review when topical care, injectables, lasers or revision surgery may enter the discussion.\n\nConsultation: Fresh-scar planning depends on anatomy, closure technique, skin history and timing.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-07-01T12:00:00Z", "date_modified": "2026-07-21T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "botulinum toxin", "scar prevention", "pathological scars", "meta-analysis", "Plastic and Reconstructive Surgery", "wound healing" ], "image": "https://myfacesurgeon.com/images/renaissance/scar-revision-study.jpg", "_source": { "name": "PubMed · Plastic and Reconstructive Surgery", "url": "https://pubmed.ncbi.nlm.nih.gov/42340826/" } }, { "id": "https://myfacesurgeon.com/trends/combined-facial-rejuvenation-2026", "url": "https://myfacesurgeon.com/trends/combined-facial-rejuvenation-2026", "title": "Why surgeons are studying combined surgical and skin-resurfacing plans.", "summary": "The American Society of Plastic Surgeons reported on research pairing face and neck lift surgery with plasma skin resurfacing. The report also emphasizes that further study is needed before broad conclusions are drawn.", "content_text": "The American Society of Plastic Surgeons reported on research pairing face and neck lift surgery with plasma skin resurfacing. The report also emphasizes that further study is needed before broad conclusions are drawn.\n\nSource lens: Professional-society research report · Further study is still needed\n\nSeamless Facelift: Explore the structural layer of a comprehensive rejuvenation plan.\n\nFacial Fat Transfer: See how volume restoration may complement-not replace-lifting and skin treatment.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-06-24T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "facelift", "neck lift", "plasma resurfacing", "combined treatment", "facial rejuvenation" ], "image": "https://myfacesurgeon.com/images/renaissance/facelift-neck-study.jpg", "_source": { "name": "American Society of Plastic Surgeons", "url": "https://www.plasticsurgery.org/news/press-releases/surgery-and-minimally-invasive-treatments-together-enhance-facial-rejuvenation" } }, { "id": "https://myfacesurgeon.com/trends/rfmn-vs-co2-acne-scars-2026", "url": "https://myfacesurgeon.com/trends/rfmn-vs-co2-acne-scars-2026", "title": "Radiofrequency microneedling matched CO2 laser scar improvement with less downtime.", "summary": "In a randomized split-face trial, radiofrequency microneedling and fractional CO2 laser both improved facial atrophic acne scars, but microneedling radiofrequency was linked to shorter redness, pain, swelling and scab-detachment time and fewer post-inflammatory hyperpigmentation events. Treatment choice still depends on scar type, skin tone, downtime tolerance and physician technique.", "content_text": "In a randomized split-face trial, radiofrequency microneedling and fractional CO2 laser both improved facial atrophic acne scars, but microneedling radiofrequency was linked to shorter redness, pain, swelling and scab-detachment time and fewer post-inflammatory hyperpigmentation events. Treatment choice still depends on scar type, skin tone, downtime tolerance and physician technique.\n\nSource lens: Randomized split-face trial · Downtime and pigment risk still vary by skin type and settings\n\nPRP + Microneedling: See how collagen-focused microneedling differs from more aggressive resurfacing paths.\n\nConsultation: Discuss whether scar depth, pigment risk and downtime point toward microneedling, laser or another plan.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-06-18T12:00:00Z", "date_modified": "2026-07-21T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "acne scars", "radiofrequency microneedling", "fractional CO2 laser", "post-inflammatory hyperpigmentation", "downtime", "split-face trial" ], "image": "https://myfacesurgeon.com/images/renaissance/prp-microneedling-study.jpg", "_source": { "name": "PubMed · Journal of Dermatological Treatment", "url": "https://pubmed.ncbi.nlm.nih.gov/42312398/" } }, { "id": "https://myfacesurgeon.com/trends/skinvive-neck-lines-2026", "url": "https://myfacesurgeon.com/trends/skinvive-neck-lines-2026", "title": "An FDA labeling update expands where SKINVIVE may be discussed.", "summary": "A June 2026 FDA supplement describes SKINVIVE by JUVEDERM for cheek smoothness and for reducing neck lines in adults over 21. Approval language does not replace an individual medical evaluation.", "content_text": "A June 2026 FDA supplement describes SKINVIVE by JUVEDERM for cheek smoothness and for reducing neck lines in adults over 21. Approval language does not replace an individual medical evaluation.\n\nSource lens: Primary regulatory source · Approval does not establish individual candidacy\n\nInjectables Reframed: Learn how skin-quality injectables differ from fillers used for contour and support.\n\nNeck Lift: Compare surface-focused treatment with surgery for deeper skin, muscle or structural laxity.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-06-11T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "SKINVIVE", "neck lines", "injectables", "FDA", "skin quality" ], "image": "https://myfacesurgeon.com/images/renaissance/injectables-study.jpg", "_source": { "name": "U.S. Food and Drug Administration", "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P110033S099" } }, { "id": "https://myfacesurgeon.com/trends/autologous-fibroblast-rejuvenation-2026", "url": "https://myfacesurgeon.com/trends/autologous-fibroblast-rejuvenation-2026", "title": "Autologous fibroblast micrografts beat a hyaluronic-acid skin booster in one small 12-month trial.", "summary": "A randomized open-label controlled study of 40 patients reported greater 12-month gains in wrinkle scores and skin elasticity with autologous fibroblast micrografts than with a hyaluronic-acid skin booster, with only mild short-lived swelling and redness reported in both groups. The study is intriguing but still small, open-label and technique-dependent, so broader replication matters before this becomes mainstream planning.", "content_text": "A randomized open-label controlled study of 40 patients reported greater 12-month gains in wrinkle scores and skin elasticity with autologous fibroblast micrografts than with a hyaluronic-acid skin booster, with only mild short-lived swelling and redness reported in both groups. The study is intriguing but still small, open-label and technique-dependent, so broader replication matters before this becomes mainstream planning.\n\nSource lens: Randomized open-label trial · Small study and technique-specific processing limit generalization\n\nSculptra® Rejuvenation: Compare injectable collagen stimulation with cell-based regenerative approaches.\n\nPRP + Microneedling: See how blood-derived regenerative treatment differs from fibroblast-based processing.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-06-01T12:00:00Z", "date_modified": "2026-07-21T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "autologous fibroblasts", "regenerative aesthetics", "skin elasticity", "wrinkles", "JPRAS Open", "micrografts" ], "image": "https://myfacesurgeon.com/images/renaissance/regenerative-study.webp", "_source": { "name": "PMC · JPRAS Open", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13285675/" } }, { "id": "https://myfacesurgeon.com/trends/facelift-restraint-newbeauty-2026", "url": "https://myfacesurgeon.com/trends/facelift-restraint-newbeauty-2026", "title": "The modern facelift conversation is moving from tighter to more precise.", "summary": "A recent NewBeauty feature describes a shift toward deeper structural repositioning, restraint and results that do not advertise the operation. It is an editorial perspective-not a universal technique rule-but it closely mirrors the question patients should ask: will the plan restore support while preserving expression and identity?", "content_text": "A recent NewBeauty feature describes a shift toward deeper structural repositioning, restraint and results that do not advertise the operation. It is an editorial perspective-not a universal technique rule-but it closely mirrors the question patients should ask: will the plan restore support while preserving expression and identity?\n\nSource lens: Editorial discovery · Technique claims require individualized surgical review\n\nSeamless Facelift: See how incision placement, structural support and natural movement shape Dr. Dagan's approach.\n\nNeck Lift: Explore when the jawline and neck should be evaluated as one connected contour.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-04-17T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "modern facelift", "natural facelift", "facelift restraint", "structural repositioning", "facial rejuvenation", "NewBeauty" ], "image": "https://myfacesurgeon.com/images/renaissance/facelift-seamless-study-v2.jpg", "_source": { "name": "NewBeauty", "url": "https://www.newbeauty.com/view/the-2026-facelift-is-about-restraint-not-tightening" } }, { "id": "https://myfacesurgeon.com/trends/natural-facial-plastic-surgery-trends-2026", "url": "https://myfacesurgeon.com/trends/natural-facial-plastic-surgery-trends-2026", "title": "Natural-looking preservation continues to shape facial plastic surgery.", "summary": "AAFPRS survey reporting points toward earlier, subtler and more strategic treatment requests, with emphasis on facial identity, preservation and long-term skin health rather than visibly overdone change.", "content_text": "AAFPRS survey reporting points toward earlier, subtler and more strategic treatment requests, with emphasis on facial identity, preservation and long-term skin health rather than visibly overdone change.\n\nSource lens: Specialty-society survey · Trend data describes populations, not an individual treatment plan\n\nSeamless Facelift: Read the Dagan MD philosophy for rejuvenation without a windswept or stretched appearance.\n\nRhinoplasty: See how identity-preserving planning applies to facial proportion and the nose.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-02-24T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "natural results", "facial plastic surgery trends", "preservation", "facial longevity", "AAFPRS" ], "image": "https://myfacesurgeon.com/images/renaissance/facial-features-study.jpg", "_source": { "name": "American Academy of Facial Plastic and Reconstructive Surgery", "url": "https://www.aafprs.org/Media/Press_Releases/New_Trends_in_Facial_Plastic_Surgery.aspx" } }, { "id": "https://myfacesurgeon.com/trends/biocorneum-bruise-system-2026", "url": "https://myfacesurgeon.com/trends/biocorneum-bruise-system-2026", "title": "A new dual-step bruise-care system enters the recovery conversation.", "summary": "BIOCORNEUM announced a two-product system marketed for use around cosmetic and surgical procedures. Claims in a company announcement require independent evaluation; patients should confirm every topical product with their treating clinician.", "content_text": "BIOCORNEUM announced a two-product system marketed for use around cosmetic and surgical procedures. Claims in a company announcement require independent evaluation; patients should confirm every topical product with their treating clinician.\n\nSource lens: Company announcement · Marketing claims require independent clinical evaluation\n\nScar Revision: Review the difference between early scar care and treatment for a mature or unfavorable scar.\n\nConsultation: Confirm every recovery product against individualized postoperative instructions.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-01-14T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "bruise care", "post procedure recovery", "BIOCORNEUM", "arnica", "cosmetic surgery recovery" ], "image": "https://myfacesurgeon.com/images/editorial/biocorneum-bruise-system-v1.webp", "_source": { "name": "BIOCORNEUM via PR Newswire", "url": "https://www.prnewswire.com/news-releases/biocorneum-announces-availability-of-new-dual-action-bruise-system-to-enhance-post-procedure-recovery-302660398.html" } }, { "id": "https://myfacesurgeon.com/trends/post-procedure-products-2026", "url": "https://myfacesurgeon.com/trends/post-procedure-products-2026", "title": "The post-procedure shelf is expanding beyond a basic moisturizer.", "summary": "NewBeauty's 2026 post-procedure selections highlight products positioned for bruising, barrier support, gentle cleansing and scar care. Product awards are editorial-not medical endorsements-and postoperative instructions from your clinician come first.", "content_text": "NewBeauty's 2026 post-procedure selections highlight products positioned for bruising, barrier support, gentle cleansing and scar care. Product awards are editorial-not medical endorsements-and postoperative instructions from your clinician come first.\n\nSource lens: Beauty-editor award coverage · Product selection never replaces postoperative instructions\n\nScar Revision: Understand when topical care may help and when a scar needs procedural evaluation.\n\nConsultation: Build a recovery plan around the actual procedure, skin and medical history.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2026-01-01T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "post procedure skin care", "bruising cream", "scar care", "gentle cleanser", "laser aftercare" ], "image": "https://myfacesurgeon.com/images/editorial/post-procedure-shelf-v1.webp", "_source": { "name": "NewBeauty", "url": "https://www.newbeauty.com/awards/2026/in-office-post-procedure" } }, { "id": "https://myfacesurgeon.com/trends/regenerative-aesthetics-2026", "url": "https://myfacesurgeon.com/trends/regenerative-aesthetics-2026", "title": "Regeneration and skin quality are moving closer to the center of aesthetic planning.", "summary": "ASPS contributors identify regenerative approaches, earlier facial procedures and laser resurfacing among the themes shaping 2026. These are trends-not proof that every featured option is appropriate for every patient.", "content_text": "ASPS contributors identify regenerative approaches, earlier facial procedures and laser resurfacing among the themes shaping 2026. These are trends-not proof that every featured option is appropriate for every patient.\n\nSource lens: Professional-society outlook · Emerging treatments vary in evidence and regulatory status\n\nSculptra® Rejuvenation: Explore gradual collagen stimulation and where it fits in a layered plan.\n\nPRP + Microneedling: Learn how controlled skin remodeling differs from structural volume restoration.\n\nInclusion is not an endorsement; treatment suitability, product safety and postoperative care require individualized guidance from a qualified clinician.", "date_published": "2025-12-29T12:00:00Z", "date_modified": "2026-07-14T12:00:00Z", "authors": [ { "name": "Tal Dagan, MD, FACS", "url": "https://myfacesurgeon.com/surgeon" } ], "tags": [ "regenerative aesthetics", "PRP", "PRF", "Sculptra®", "laser resurfacing", "skin quality" ], "image": "https://myfacesurgeon.com/images/renaissance/sculptra-rejuvenation-study.jpg", "_source": { "name": "American Society of Plastic Surgeons", "url": "https://www.plasticsurgery.org/news/articles/looking-into-the-future-plastic-surgery-trends-for-2026" } } ] }